Medicure Inc V.MPH

Alternate Symbol(s): MCUJF

Healthcare Biotechnology

Medicure Inc. is a Canada-based pharmaceutical company. The Company is focused on the development and commercialization of therapies for the United States cardiovascular market. The focus of the Company is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company’s United States subsidiary, Medicure Pharma Inc. The Company also operates Marley Drug, Inc. (Marley Drug), a pharmacy located in North Carolina that offers an Extended Supply drug program serving all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving the health status of its patients and the communities they serve while reducing overall health care costs for employers and other health care consumers. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome (NSTE-ACS).

TSXV:MPH - Post by User

Medicure Inc > what have you ever done besides call successful people

<< Previous

Bullboard Posts

Next >>

Comment by Winnipeg40on Apr 28, 2022 9:44am

222 Views

Post# 34638506

RE:RE:what have you ever done besides call successful people

1.8 Million dollar gain on the Contingent Consideration....means their new drug store aquisition is another example of Management overpaying for an asset. Take out the Wage Subsidy and loss over a million bucks. 10 cents a share on an 85 cent share...So sad....the flagship drug soon off patent, margins will get squeezed and bye bye

<< Previous

Bullboard Posts

Next >>

Morning Market Outlook for April 26, 2024